red22
Bluelighter
- Joined
- Nov 23, 2009
- Messages
- 1,205
Got this ad (mod edit: not from Bluelight). It's a pressing topic in the psychedelic movement, but the content is paywalled…
Join a live webinar workshop focused on the Cardiovascular Risks and Effects of Psychedelics
As the therapeutic and spiritual use of psychedelics gains popularity, it is critical to understand the cardiovascular risks associated with their use, particularly among individuals with pre-existing heart conditions or risk factors. This webinar will provide a detailed examination of the cardiovascular effects of a range of psychedelics, including tryptamine and ergoline compounds like psilocybin, LSD, and DMT, as well as the dissociative ketamine and phenethylamines such as MDMA.
Join me on Saturday, May 17th, 9 am - 11:30 am Mountain Time US for a deep dive into these topics. You can use the [link] below to register, see more background details, and review important webinar logistics below:
Who Should Attend
Webinar Background and Description
Participants will gain an evidence-informed framework for cardiovascular screening, learn to assess intrinsic and extrinsic risk factors, and explore pharmacologic mechanisms underlying hemodynamic changes during psychedelic experiences. The session will also address limitations in current clinical trial data, discuss risk profiles across different routes of administration, and highlight harm reduction practices tailored to cardiovascular health.
By integrating observational findings, clinical pharmacology, and practical strategies, this webinar aims to empower clinicians, facilitators, and healthcare practitioners to make informed decisions about candidate eligibility, session preparation, and emergency response planning. Special attention will be given to identifying populations at elevated risk, medication considerations, and best practices for managing acute cardiovascular events in psychedelic settings.
Learning Objectives:
Important Webinar Details
Really looking forward to speaking to this complex subject and topics. Space is limited, so make sure to sign up and reserve your spot today.
Hope to see you there.
Kind regards,
Ben
Ben Malcolm, PharmD, MPH
Spirit Pharmacist
Webinar Disclaimer
This webinar is for information and educational purposes only. It is not meant to condone or encourage the use of illicit substances. The information presented is not medical advice and should not be taken as such. It is recommended you follow laws applicable to your jurisdiction.
Join a live webinar workshop focused on the Cardiovascular Risks and Effects of Psychedelics
As the therapeutic and spiritual use of psychedelics gains popularity, it is critical to understand the cardiovascular risks associated with their use, particularly among individuals with pre-existing heart conditions or risk factors. This webinar will provide a detailed examination of the cardiovascular effects of a range of psychedelics, including tryptamine and ergoline compounds like psilocybin, LSD, and DMT, as well as the dissociative ketamine and phenethylamines such as MDMA.
Join me on Saturday, May 17th, 9 am - 11:30 am Mountain Time US for a deep dive into these topics. You can use the [link] below to register, see more background details, and review important webinar logistics below:
Who Should Attend
- This webinar is designed for medical professionals, psychedelic facilitators, integration coaches, retreat center operators, and individuals involved in psychedelic care who seek a deeper, practical understanding of cardiovascular safety considerations.
- Attendance of this workshop is expected to be eligible for Continuing Facilitator Education credit specific to Oregon Psilocybin Facilitators
Webinar Background and Description
Participants will gain an evidence-informed framework for cardiovascular screening, learn to assess intrinsic and extrinsic risk factors, and explore pharmacologic mechanisms underlying hemodynamic changes during psychedelic experiences. The session will also address limitations in current clinical trial data, discuss risk profiles across different routes of administration, and highlight harm reduction practices tailored to cardiovascular health.
By integrating observational findings, clinical pharmacology, and practical strategies, this webinar aims to empower clinicians, facilitators, and healthcare practitioners to make informed decisions about candidate eligibility, session preparation, and emergency response planning. Special attention will be given to identifying populations at elevated risk, medication considerations, and best practices for managing acute cardiovascular events in psychedelic settings.
Learning Objectives:
- Outline a systematic rationale for cardiovascular screening prior to psychedelic experiences
- Describe the hemodynamic effects of ketamine and serotonergic psychedelics and their clinical implications
- Recognize key cardiovascular risk factors, stratify risk severity, and assess medication profiles
- Understand emergency preparedness strategies and harm reduction approaches to mitigate cardiovascular complications
- Critically evaluate the gaps in current clinical trial data and their relevance to real-world practice
- Review case example intake forms and discuss their contents
Important Webinar Details
- The live workshop will take place on Sat May 17th from 9a-11:30am mountain time US
- Registration is 35$
- Includes the live webinar workshop, access to a copy of the video recording, as well as downloadable PDF slides
- The workshop will consist of a 60-75 min lecture, short break, 30-40 min break out group case discussion, and 30 min case review Q&A session
- There will be no refunds issued for the event in the circumstances you're unable to attend
- The recording will be available for viewing 72 hours after the completion of the live event
- Registration will trigger emails that have the workshop information containing the attendance link. The attendance link will also be available on the webpage immediately following registration. It is your responsibility to follow up at [email protected] if you do not receive these emails at least 24 hours prior to the event
- In the case of gross technical difficulties or other circumstances (e.g., illness, medical emergency) significantly effecting the workshop quality or precluding its occurrence, the workshop will be rescheduled to a different time
Really looking forward to speaking to this complex subject and topics. Space is limited, so make sure to sign up and reserve your spot today.
Hope to see you there.
Kind regards,
Ben
Ben Malcolm, PharmD, MPH
Spirit Pharmacist
Webinar Disclaimer
This webinar is for information and educational purposes only. It is not meant to condone or encourage the use of illicit substances. The information presented is not medical advice and should not be taken as such. It is recommended you follow laws applicable to your jurisdiction.
Last edited by a moderator:
